LEXINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to welcome Dr. Dafni Bika to the Company’s Board of Directors (the “Board”). “We are extremely pleased to welcome Dr. Bika to our Board of Directors,” said Robert Spignesi, President and C ...

Rapid Micro Biosystems (RPID) Q1 2025 Earnings Call May 09, 2025 08:30 AM ET Company Participants Michael Beaulieu - Vice President of Investor Relations & Corporate CommunicationsSean Wirtjes - Chief Financial OfficerDan Arias - Managing DirectorRobert Spignesi - CEO, President & DirectorPaul Knight - Managing DirectorChad Wiatrowski - VP - Equity Research Operator Thank you for standing by. My name is RG, and I will be your conference operator today. At this time, I would like to welcome everyone to the R ...

Rapid Micro Biosystems (RPID) Q1 2025 Earnings Call May 09, 2025 08:30 AM ET Speaker0 Thank you for standing by. My name is RG, and I will be your conference operator today. At this time, I would like to welcome everyone to the Rapid Micro Biosystems First Quarter twenty twenty five Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. Thank you. I would now like to turn the call over to Mike Bu ...

Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter gross margin of 6%, representing a 33-percentage point improvement compared to the first quarter of 2024.Announced a global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates in the U.S. as MilliporeSigma (“MilliporeSigma ...

文章核心观点 - 创新生命科学技术公司Rapid Micro Biosystems将于2025年5月9日开盘前发布2025年第一季度财务结果，管理层将在同日上午8:30举办网络直播电话会议 [1][2] 公司信息 - 公司为创新生命科学技术公司，提供关键任务自动化解决方案，助力医疗产品高效制造与快速安全放行 [1][3] - 旗舰产品Growth Direct系统可自动化和现代化微生物质量控制测试工作流程，带来更快结果、更高准确性等优势 [3] - 公司总部位于马萨诸塞州列克星敦，在马萨诸塞州洛厄尔有美国制造工厂，在瑞士、德国和荷兰设有全球办事处 [3] 联系方式 - 投资者联系：Michael Beaulieu，邮箱investors@rapidmicrobio.com [4] - 媒体联系：邮箱media@rapidmicrobio.com [4] 会议信息 - 2025年5月9日上午8:30举办网络直播电话会议，可通过公司网站链接访问，会议将存档供回放 [2]